Neuronetics (STIM) Cash from Investing Activities (2017 - 2026)
Neuronetics (STIM) reported Cash from Investing Activities of -$172000.0 for Q1 2026, up 21.46% year-over-year from -$141609.0 in Q1 2025, and up 20.37% quarter-over-quarter from -$216000.0 in Q4 2025.
Neuronetics (STIM) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Cash from Investing Activities data on file, last reported at -$172000.0 in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$172000.0, up 21.46% year-over-year; the trailing twelve-month figure through Mar 2026 was -$754000.0 (up 72.07% YoY), and the FY2025 annual result was -$801000.0, up 66.8% from the prior year.
- Cash from Investing Activities advanced to -$172000.0 in Q1 2026 per STIM's latest filing, from -$216000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $9.3 million in Q3 2022 and troughed at -$2.4 million in Q4 2024.
- A 5-year average of $119000.0 and a median of -$216000.0 in 2025 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities soared 216.95% in 2022, then sank 914.29% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$503000.0 in 2022, then fell by 11.93% to -$563000.0 in 2023, then slumped by 322.02% to -$2.4 million in 2024, then soared by 90.91% to -$216000.0 in 2025, then climbed by 20.37% to -$172000.0 in 2026.
- Business Quant data shows STIM's Cash from Investing Activities at -$172000.0 in Q1 2026, -$216000.0 in Q4 2025, and -$114000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Neuronetics | 2.61 Mn | -7.06 Mn | 16.15 Mn | -172,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172,000.00 |
| Mar 31, 2026 | -172,000.00 |
| Dec 31, 2025 | -216,000.00 |
| Dec 31, 2025 | -216,000.00 |
| Sep 30, 2025 | -114,000.00 |
| Sep 30, 2025 | -114,000.00 |
| Jun 30, 2025 | -252,000.00 |
| Jun 30, 2025 | -252,000.00 |
| Mar 31, 2025 | -219,000.00 |
| Mar 31, 2025 | -219,000.00 |
| Dec 31, 2024 | -2.38 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | -563,000.00 |
| Dec 31, 2023 | -563,000.00 |